Joseph Ahn, M.D. M.S. M.B.A, is a hepatologist at Endeavor Health in Chicago, Illinois. He serves as the Division Chief of Gastroenterology and Hepatology. Dr. Ahn is Board Certified in Internal Medicine, Gastroenterology, and Transplant Hepatology. He received his medical degree from Northwestern University and completed his residency in internal medicine at the University of Chicago. He trained at Northwestern University as a fellow in hepatology and gastroenterology. As a hepatologist, he treats patients with chronic liver diseases.

Michael Lin, MD is a transplant hepatologist and Assistant Professor in the Division of Gastrointestinal and Liver Diseases, Keck School of Medicine at the University of Southern California. He received his medical degree from Feinberg School of Medicine at Northwestern University, completed his gastroenterology fellowship at Baylor College of Medicine, and completed his transplant hepatology fellowship at the University of California, San Francisco.

Dr. Junna is an Assistant Professor of Gastroenterology and Transplant Hepatology at the Cleveland Clinic. Her academic interests include liver transplantation, liver tumors, and DILI including ICI hepatitis and DI-ALH. She is currently the Medical Director of the Liver Tumor Program at the Cleveland Clinic and is passionate about advancing diagnostic and treatment modalities for primary liver cancers and CRLM, including increasing access to liver transplantation.

Director of Hepatology Research, Department of Gastroenterology, Hepatology and Nutrition at Cleveland Clinic (Cleveland, OH).

Lewis R. Roberts, MB ChB, PhD, FACP, is the Peter and Frances Georgeson Professor in Gastroenterology Cancer Research and Consultant in Gastroenterology and Hepatology at the Mayo Clinic, where he is Co-Principal Investigator of the Mayo Clinic Specialized Program of Research Excellence (SPORE) in Hepatobiliary Cancers. Dr. Roberts' research focuses on mechanisms of liver and biliary carcinogenesis; biomarkers for liver, biliary and pancreas cancers; and prevention, diagnosis and treatment of hepatitis and liver cancer.

I am a Transplant Hepatologist with additional training in Critical Care medicine. My passion is the treatment of critically ill patients with liver disease, particularly those with acute liver failure, and management of hospitalized patients before and after liver transplantation. I am currently the Medical Director of the University of Minnesota Donor Care Unit - a specialized ICU responsible for maximizing the gift of organ donation.

Michael (Andrew) Yu is an assistant professor at Emory University where he practices both transplant hepatology and interventional endoscopy. He earned his internal medicine residency and GI/transplant hepatology fellowships at Emory University, followed by advanced endoscopy fellowship at UC Irvine and Hoag. He is interested in the roles of interventional endoscopic ultrasound and bariatric endoscopy in the care of patients with liver disease.

Longgang Zhao is a postdoctoral researcher at Yale School of Nursing with expertise in nutritional epidemiology and cancer prevention. His research centers on the role of diet, metabolism, and inflammation in the development of liver disease and liver cancer.